Zimmer Biomet (ZBH)
(Delayed Data from NYSE)
$121.51 USD
+0.73 (0.60%)
Updated Apr 23, 2024 03:59 PM ET
3-Hold of 5 3
B Value D Growth A Momentum B VGM
Income Statements
Fiscal Year end for Zimmer Biomet Holdings, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 7,394 | 6,940 | 7,836 | 7,025 | 7,982 |
Cost Of Goods | 2,084 | 2,020 | 2,341 | 2,128 | 2,253 |
Gross Profit | 5,310 | 4,920 | 5,495 | 4,896 | 5,730 |
Selling & Adminstrative & Depr. & Amort Expenses | 4,033 | 4,224 | 4,715 | 4,984 | 4,592 |
Income After Depreciation & Amortization | 1,278 | 696 | 780 | -88 | 1,138 |
Non-Operating Income | -9 | -128 | -153 | 25 | -5 |
Interest Expense | 201 | 165 | 208 | 212 | 227 |
Pretax Income | 1,067 | 404 | 418 | -274 | 906 |
Income Taxes | 42 | 112 | 16 | -137 | -226 |
Minority Interest | 1 | 1 | 1 | 2 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1,025 | 290 | 402 | -137 | 1,132 |
Extras & Discontinued Operations | 0 | -59 | 0 | 0 | 0 |
Net Income (GAAP) | 1,024 | 231 | 402 | -139 | 1,132 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 2,229 | 1,916 | 1,864 | 1,590 | 2,214 |
Depreciation & Amortization (Cash Flow) | 952 | 1,219 | 1,084 | 1,678 | 1,076 |
Income After Depreciation & Amortization | 1,278 | 696 | 780 | -88 | 1,138 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 209.70 | 210.30 | 210.40 | 207.00 | 206.70 |
Diluted EPS Before Non-Recurring Items | 7.55 | 6.89 | 7.37 | 5.67 | 7.87 |
Diluted Net EPS (GAAP) | 4.88 | 1.10 | 1.91 | -0.67 | 5.47 |
Fiscal Year end for Zimmer Biomet Holdings, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 1,940.00 | 1,753.60 | 1,869.60 | 1,831.00 |
Cost Of Goods | NA | 538.90 | 518.60 | 525.50 | 500.80 |
Gross Profit | NA | 1,401.10 | 1,235.00 | 1,344.10 | 1,330.20 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1,047.10 | 968.40 | 1,014.40 | 1,002.80 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 354.00 | 266.60 | 329.70 | 327.40 |
Non-Operating Income | NA | -19.60 | 3.80 | -1.20 | 7.70 |
Interest Expense | NA | 50.30 | 51.10 | 51.60 | 48.20 |
Pretax Income | NA | 284.50 | 219.20 | 276.80 | 286.80 |
Income Taxes | NA | -135.20 | 56.40 | 66.90 | 54.10 |
Minority Interest | NA | 0.70 | 0.20 | 0.20 | 0.20 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 419.70 | 162.70 | 209.90 | 232.80 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 419.00 | 162.70 | 209.70 | 232.60 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 208.60 | 210.00 | 209.90 | 210.40 |
Diluted EPS Before Non-Recurring Items | NA | 2.20 | 1.65 | 1.82 | 1.89 |
Diluted Net EPS (GAAP) | NA | 2.00 | 0.77 | 1.00 | 1.11 |